Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's disease (Q40808512)
Jump to navigation
Jump to search
scientific article published on June 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's disease |
scientific article published on June 1999 |
Statements
1 reference
Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's disease (English)
1 reference
Reece DE
1 reference
Nevill TJ
1 reference
Sayegh A
1 reference
Spinelli JJ
1 reference
Brockington DA
1 reference
Barnett MJ
1 reference
Klingemann HG
1 reference
Connors JM
1 reference
Nantel SH
1 reference
Shepherd JD
1 reference
Sutherland HJ
1 reference
Voss NJ
1 reference
Fairey RN
1 reference
O'Reilly SE
1 reference
Phillips GL
1 reference
1 June 1999
1 reference
1 reference
23
1 reference
11
1 reference
1131-1138
1 reference
Identifiers
1 reference
1 reference